期刊文献+

TGF-β_1基因-509C/T单核苷酸多态性与病理性瘢痕易感性研究 被引量:2

TGFβ_1-509C/T polymorphism and susceptibility to abnormal scar in Han Nationality of Chinese population
下载PDF
导出
摘要 目的:探讨转化生长因子β1(TGF-β1)基因-509C/T多态性与中国汉族人群病理性瘢痕的相关关系。方法:采用聚合酶链反应-反向点杂交、DNA直接测序方法检测了155例病理性瘢痕患者与120名正常对照的TGF-β1基因-509C/T多态性位点的基因型。结果:病理性瘢痕患者的C等位基因频率明显高于正常对照组(χ2=4.676,P=0.031)。病理性瘢痕患者的C/T、T/T基因型频率与正常对照组相比差异无统计学意义(χ2值分别为0.763和1.376;P值分别为0.382和0.241),而病理性瘢痕患者的C/C基因型频率明显高于对照组(χ2=5.493,P=0.019)。提示C/C基因型者患病理性瘢痕的风险性明显高于C/T、T/T基因型者(OR=2.041,95%CI:1.116~3.73)。结论:TGF-β1基因-509位点C等位基因及C/C基因型可能是病理性瘢痕的易感因素。 Objective To investigate the relationship between TGFβ1-509C/T polymorphism and susceptibility to abnormal scar in a southern Chinese population. Methods The TGFβ1-509 genotypes were determined by polymerase chain reaction-reverse dot blot (PCR-RDB) and DNA direct sequencing in 155 patients with abnormal scar and 120 unrelated healthy controls. Results The frequency of the TGFβ1-509 C allele among abnormal scar patients was significantly higher than that among healthy controls (χ^2=4.676,P=0.031). The C/T and T/T genotype distribution among abnormal scar patients was not significantly different from that among healthy controls (χ^2=0.763and 1.376; P=0.382 and 0.241, respectively). However, the C/C genotype frequency among abnormal scar patients was significantly higher than that among healthy controls (χ^2=5.493,P=0.019). The TGFβ1-509 C/C genotype significantly increased the risk for developing abnormal scar,compared to the combination of C/T and T/T genotypes,with the odds ratio(OR) of 2.041, (95% CI: 1.116-3.731). Conclusion The TGFβ1-509 polymorphism may play a role in susceptibility to abnormal scar.
机构地区 温州解放军第
出处 《中国美容医学》 CAS 2008年第8期1170-1172,共3页 Chinese Journal of Aesthetic Medicine
基金 浙江省温州市科技计划项目(Y20060121)
关键词 病理性瘢痕 TGF-Β1基因 多态性 遗传易感性 abnormal scar TGFβ1 gene polymorphism genetic susceptibility
  • 相关文献

参考文献8

  • 1Oyama A. High expression of macrophage migration inhibitory factor and its role in cellular proliferation and extracellular matrix production in keloid fibroblasts[J], Hokkaido Igaku Zasshi, 2003,78(6):529-539.
  • 2Wu Y, Zhang Q, Ann DK,et al.Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts [J].Am JPhysiol Cell Physiol, 2004,286(4):C905-912.
  • 3Widgerow AD, Chait LA, Stals R, et al.New innovations in scar management[J].Aesthetic Plast Surg, 2000,24(3):227-234.
  • 4Schultze-Mosgau S, Blaese MA, Grabenbauer Get al.Smad-3 and Smad-7 expression following anti-transforming growth factor beta 1(TGFbeta1)-treatment in irradiated rat tissue [J]. Radiother Oncol, 2004,70(3):249-259.
  • 5Flanders KC, Major CD, Arabshahi A, et alJnterference with transforming growth factor-beta/Smad3 signaling results in accelerated healing ofwotmds in previously irradiated skin[J]. Am J Pathol,2003,163 (6):2247-2257.
  • 6Dunning AM, Ellis PD ,McBride S, et al. A transforming growth factor betal signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer [J].Cancer Res, 2003,63(10) :2610-2615.
  • 7Li Z ,Habuchi T, Tsuchiya Net al. Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor2be2ta 1 gene polymorphism at codon10[J].Carcinogenesis, 2004,25(2):237-240.
  • 8Saiki RK,Walsh PS,Levenson CH.Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes [J]. Proc Natl Acad Sci USA. 1989,86:6230-6234.

同被引文献26

  • 1陈伟,付小兵,葛世丽,周岗,孙同柱,盛志勇.瘢痕疙瘩和正常皮肤组织中基因表达的变化[J].解放军医学杂志,2004,29(8):655-657. 被引量:4
  • 2陈阳,高建华,刘晓军,严欣,宋玫.瘢痕疙瘩中国家系的发病特点研究[J].中国美容医学,2006,15(1):6-10. 被引量:20
  • 3Brown JJ, Bayat A. Genetic susceptibility to raised dermal scar- ring[J]. Br J Dermatol, 2009,161(1):8-18.
  • 4Emami A, Halim AS, Salahshourifar I, et al. Association of TGFI31 and SMAD4 variants in the etiology of keloid scar in the Malay population [ J ]. Arch Dermatol Res, 2012,304 ( 7 ) : 541 -547.
  • 5Zhang G, Jiang J,Luo S, et al. Analyses of CDC2L1 gene muta- tions in keloid tissue [ J]. Clin Exp Dermatol, 2012,37 (3) :277- 283.
  • 6Vishnoi M,Pandey SN,Modi DR, et al. Genetic susceptibility of epidermal growth faetor+ 61A > G and transforming growth factor betal -509C > T gene polymorphisms with gallbladder cancer[ J]. Hum lmmunol, 2008,69(6) :360-367.
  • 7Konikoff CE, Wisotzkey RG, Stinchfield M J, et al. Distinct molecular evolutionary mechanisms underlie the functional diversi- fieation of the Wnt and TGFbeta signaling pathways [ J ]. J Mol Evol, 2010,70(4) :303-312.
  • 8Achyut BR, Ghoshal UC, Moorchung N, et al. Transforming growth factor-131 and matrix metalloproteinase-7 promoter variants induce risk for Helicobacter pylori-associated gastric precancerous lesions[J]. DNA Celt Biol, 2009,28(6) :295-301.
  • 9Khalil MS, EI Nahas AM, Blakemore AI. Transforming growth factor-betal SNPs: genetic and phenotypic correlations in progres- sive kidney insufficiency[ J]. Nephron Exp Nephrol, 2005, 101 (2) :e31-41.
  • 10Bayat A, Bock O, Mrowietz U, et al. Genetic susceptibility to ke- loid disease and hypertrophic scarring: transforming growth factor 131 common polymorphisms and plasma levels[ J]. Plast Reconstr Surg, 2003,111 ( 2 ) : 534-543 ; discussion 544-546.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部